Question of the Day – Tuesday December 26, 2017

Question: Cisplatin is commonly associated with hearing loss in adults receiving this drug. What is the prevalence of hearing loss due to cisplatin therapy?

Answer: Them cited reference notes “Among adults who have received cisplatin, clinically significant hearing loss develops in approximately 60% of patients with testicular cancer and 65% of patients with head and neck cancer. (Cunningham LL and Tucci DL. Hearing loss in adults. 2017 NEJM, 377(25):2465-2473)